Nelarabine 5 mg/mL (Nelarabine INJECTION, SOLUTION) 5 mg/mL

Nelarabine 5 mg/mL is an injectable solution used in cancer treatment. This medication is administered intravenously and is available in 50 mL vials. Learn more about its uses and effects.

Strength

5 mg/mL

Pack Size

6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nelarabine 5 mg/mL is primarily used in the treatment of certain types of cancer. It is often prescribed for conditions where other treatments have not been effective. The medication works by targeting specific cells in the body to help manage the disease. Patients and healthcare providers often discuss what is Nelarabine used for in the context of personalized treatment plans.

Side Effects

Common effects of Nelarabine 5 mg/mL may include fatigue, nausea, and changes in blood cell counts. Some individuals might experience more severe reactions, and it is important to monitor for any unusual symptoms. The effects can vary widely depending on the individual and their specific health condition.

Precautions & Warnings

Nelarabine 5 mg/mL should be handled with care and administered by a healthcare professional. It is important to follow all safety guidelines provided by the manufacturer and healthcare provider. Proper storage and handling are crucial to ensure the medication remains effective and safe for use.

Avoid Interactions

Nelarabine 5 mg/mL may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how the medication works.

References

Frequently Asked Questions

Nelarabine 5 mg/mL is used in the treatment of certain types of cancer, often when other treatments have not been effective.

Nelarabine 5 mg/mL is administered intravenously by a healthcare professional.

Common effects may include fatigue, nausea, and changes in blood cell counts.

It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Nelarabine 5 mg/mL should be stored according to the manufacturer's guidelines to ensure its effectiveness and safety.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.